Singapore private-equity firm Everstone Capital is exploring an initial public offering of its Asian health services firm as plans to sell that business remain stuck.
![](https://immunet.online/wp-content/uploads/2024/05/medium-ETJron.jpeg)
Singapore private-equity firm Everstone Capital is exploring an initial public offering of its Asian health services firm as plans to sell that business remain stuck.